Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/jcb.30166 http://scihub22266oqcxt.onion/10.1002/jcb.30166 34668225!9088732!34668225     free     free     free  :  Publisher Nephropedia Template TP {{tp|p=34668225|t=2022. Harnessing autophagy to fight SARS-CoV-2: An update in view of recent drug development efforts |pdf=|usr=}} gab.com Text Harnessing autophagy to fight SARS-CoV-2: An update in view of recent drug development efforts JO: J Cell Biochem http://www.kidney.de/pget.php?&tw=1&pmid=34668225 #FOAvip Drug repurposing is an attractive option for identifying new treatment strategies, in particular in extraordinary situations of urgent need such as the current coronavirus disease 2019 (Covid-19) pandemic. Recently, the World Health Organization announced testing of three drugs as potential Covid-19 therapeutics that are known for their dampening effect on the immune system. Thus, the underlying concept of selecting these drugs is to temper the potentially life-threatening overshooting of the immune system reacting to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. This viewpoint discusses the possibility that the impact of these and other drugs on autophagy contributes to their therapeutic effect by hampering the SARS-CoV-2 life cycle. Twit Text FOAVip Harnessing autophagy to fight SARS-CoV-2: An update in view of recent drug development efforts 🦆🦆J Cell Biochem http://www.kidney.de/pget.php?&tw=1&pmid=34668225 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34668225 #FOAvip English Wikipedia <ref>{{Cite pmid|34668225}}</ref> Harnessing autophagy to fight SARS-CoV-2: An update in view of recent drug development efforts #MMPMID34668225 Rein T J Cell Biochem 2022[Feb]; 123 (2): 155-160 PMID34668225show ga Drug repurposing is an attractive option for identifying new treatment strategies, in particular in extraordinary situations of urgent need such as the current coronavirus disease 2019 (Covid-19) pandemic. Recently, the World Health Organization announced testing of three drugs as potential Covid-19 therapeutics that are known for their dampening effect on the immune system. Thus, the underlying concept of selecting these drugs is to temper the potentially life-threatening overshooting of the immune system reacting to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. This viewpoint discusses the possibility that the impact of these and other drugs on autophagy contributes to their therapeutic effect by hampering the SARS-CoV-2 life cycle. |*Drug Repositioning[MESH] |*Pandemics[MESH] |Antidepressive Agents/pharmacology[MESH] |Antiviral Agents/*pharmacology/therapeutic use[MESH] |Artesunate/*pharmacology/therapeutic use[MESH] |Autophagy/*drug effects[MESH] |COVID-19/*drug therapy[MESH] |Chloroquine/pharmacology[MESH] |Drug Development[MESH] |Endoplasmic Reticulum/drug effects/physiology/virology[MESH] |Endosomes/drug effects/virology[MESH] |Humans[MESH] |Hydroxychloroquine/pharmacology[MESH] |Imatinib Mesylate/*pharmacology/therapeutic use[MESH] |Infliximab/*pharmacology/therapeutic use[MESH] |Intracellular Membranes/drug effects/physiology/virology[MESH] |Ivermectin/pharmacology[MESH] |Macrolides/pharmacology[MESH] |Middle East Respiratory Syndrome Coronavirus/drug effects[MESH] |Niclosamide/pharmacology/therapeutic use[MESH] |RNA, Viral/metabolism[MESH] |SARS-CoV-2/*drug effects/physiology[MESH] |Virus Replication[MESH]Harnessing autophagy to fight SARS-CoV-2: An update in view of recent (epmc).pdf DeepDyve Pubget Overpricing